These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28051254)

  • 1. MiR-214 negatively regulates proliferation and WNT/β-catenin signaling in breast cancer.
    Yi SJ; Li LL; Tu WB
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5148-5154. PubMed ID: 28051254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
    Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
    Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
    Liu F; Liu Y; Shen J; Zhang G; Han J
    Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling.
    Fu Q; Gao Y; Yang F; Mao T; Sun Z; Wang H; Song B; Li X
    Biomed Pharmacother; 2018 Jan; 97():120-127. PubMed ID: 29080452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-340-5p suppresses osteosarcoma development by down-regulating the Wnt/β-catenin signaling pathway via targeting the STAT3 gene.
    Rongxin S; Pengfei L; Li S; Xiaochen J; Yihe H
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):982-991. PubMed ID: 30779064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-200c promotes proliferation of papillary thyroid cancer cells via Wnt/β-catenin signaling pathway.
    Ren ZF; Du MF; Fu H; Liu J; Xia FY; Du HN; Liu N
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5512-5518. PubMed ID: 32495886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of NEAT1/miR-214-3p on the growth, migration and invasion of endometrial carcinoma cells.
    Wang J; Zhao X; Guo Z; Ma X; Song Y; Guo Y
    Arch Gynecol Obstet; 2017 Jun; 295(6):1469-1475. PubMed ID: 28447190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
    Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
    Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Dickkopf-1 is responsible for high proliferation of breast cancer cells via losing control of Wnt/beta-catenin signaling.
    Zhou XL; Qin XR; Zhang XD; Ye LH
    Acta Pharmacol Sin; 2010 Feb; 31(2):202-10. PubMed ID: 20139903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway.
    He SZ; Wang Q
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The repressive effect of miR-148a on Wnt/β-catenin signaling involved in Glabridin-induced anti-angiogenesis in human breast cancer cells.
    Mu J; Zhu D; Shen Z; Ning S; Liu Y; Chen J; Li Y; Li Z
    BMC Cancer; 2017 May; 17(1):307. PubMed ID: 28464803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
    Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
    Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-770 inhibits tumorigenesis and EMT by targeting JMJD6 and regulating WNT/β-catenin pathway in non-small cell lung cancer.
    Zhang Z; Yang Y; Zhang X
    Life Sci; 2017 Nov; 188():163-171. PubMed ID: 28882645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-125b regulates the proliferation and metastasis of triple negative breast cancer cells via the Wnt/β-catenin pathway and EMT.
    Nie J; Jiang HC; Zhou YC; Jiang B; He WJ; Wang YF; Dong J
    Biosci Biotechnol Biochem; 2019 Jun; 83(6):1062-1071. PubMed ID: 30950326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
    Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
    Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
    Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
    Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/β-catenin pathway.
    Shi S; Chen X; Liu H; Yu K; Bao Y; Chai J; Gao H; Zou L
    Gene; 2019 Jan; 683():47-53. PubMed ID: 30300682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.